Physitrack PLC (PTRK.ST)
SEK 8.72
(4.06%)
SEK 8.72
(4.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.86 Million EUR | -68.74% |
| 2022 | 12.36 Million EUR | 58.31% |
| 2021 | 7.81 Million EUR | 34.04% |
| 2020 | 5.82 Million EUR | 385.07% |
| 2019 | 1.2 Million EUR | 40.19% |
| 2018 | 857 Thousand EUR | 91.55% |
| 2017 | 447.41 Thousand EUR | 88.33% |
| 2016 | 237.56 Thousand EUR | 438.83% |
| 2015 | 44.08 Thousand EUR | 86.12% |
| 2014 | 23.68 Thousand EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.05 Million EUR | 12.39% |
| 2024 Q2 | 891.91 Thousand EUR | -15.47% |
| 2023 Q4 | 938.79 Thousand EUR | -10.69% |
| 2023 Q1 | 922.09 Thousand EUR | 133.39% |
| 2023 Q2 | 953.65 Thousand EUR | 3.42% |
| 2023 Q3 | 1.05 Million EUR | 10.22% |
| 2023 FY | 3.86 Million EUR | -68.74% |
| 2022 Q3 | 917 Thousand EUR | 1.53% |
| 2022 Q1 | 749.78 Thousand EUR | 157.36% |
| 2022 FY | 12.36 Million EUR | 58.31% |
| 2022 Q4 | -2.76 Million EUR | -401.15% |
| 2022 Q2 | 903.14 Thousand EUR | 20.45% |
| 2021 Q1 | 1.84 Million EUR | -49.99% |
| 2021 FY | 7.81 Million EUR | 34.04% |
| 2021 Q4 | -1.3 Million EUR | -325.96% |
| 2021 Q3 | 578.46 Thousand EUR | -70.2% |
| 2021 Q2 | 1.94 Million EUR | 5.34% |
| 2020 FY | 5.82 Million EUR | 385.07% |
| 2020 Q4 | 3.68 Million EUR | 276.96% |
| 2020 Q3 | 977.7 Thousand EUR | 28.52% |
| 2020 Q2 | 760.72 Thousand EUR | 88.49% |
| 2020 Q1 | 403.59 Thousand EUR | 0.0% |
| 2019 FY | 1.2 Million EUR | 40.19% |
| 2018 FY | 857 Thousand EUR | 91.55% |
| 2017 FY | 447.41 Thousand EUR | 88.33% |
| 2016 FY | 237.56 Thousand EUR | 438.83% |
| 2015 FY | 44.08 Thousand EUR | 86.12% |
| 2014 FY | 23.68 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aino Health AB (publ) | 3.79 Million SEK | -1.781% |
| Bonzun AB (publ) | -25.25 Million SEK | 115.306% |
| Kontigo Care AB (publ) | 2.74 Million SEK | -40.774% |
| Medhelp Care Aktiebolag (publ) | 90.38 Million SEK | 95.723% |
| RaySearch Laboratories AB (publ) | 630.37 Million SEK | 99.387% |
| Surgical Science Sweden AB (publ) | 558.88 Million SEK | 99.308% |